Agiliti Stock Forecast, Price & News

Agiliti (NYSE:AGTI) Frequently Asked Questions

Is Agiliti a buy right now?

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agiliti in the last twelve months. There are currently 1 hold rating and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Agiliti stock.
View analyst ratings for Agiliti or view top-rated stocks.

What stocks does MarketBeat like better than Agiliti?

Wall Street analysts have given Agiliti a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Agiliti wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Agiliti's next earnings date?

Agiliti is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Agiliti.

How were Agiliti's earnings last quarter?

Agiliti, Inc. (NYSE:AGTI) posted its quarterly earnings results on Thursday, August, 12th. The company reported $0.21 earnings per share for the quarter, meeting the Zacks' consensus estimate of $0.21. The firm earned $250.54 million during the quarter, compared to analysts' expectations of $242.45 million.
View Agiliti's earnings history.

What guidance has Agiliti issued on next quarter's earnings?

Agiliti updated its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $965 million-$980 million, compared to the consensus revenue estimate of $971.11 million.

What price target have analysts set for AGTI?

9 brokerages have issued 1-year target prices for Agiliti's stock. Their forecasts range from $16.00 to $43.00. On average, they anticipate Agiliti's share price to reach $23.25 in the next year. This suggests a possible upside of 21.3% from the stock's current price.
View analysts' price targets for Agiliti or view top-rated stocks among Wall Street analysts.

Who are Agiliti's key executives?

Agiliti's management team includes the following people:

• Thomas J. Leonard, Chief Executive Officer & Director
• Thomas W. Boehning, President
• James B. Pekarek, Chief Financial Officer & Executive Vice President
• Lee Neumann, Senior Vice President & General Counsel
• Scott A. Christensen, Chief Accounting Officer, VP & Controller

Who are some of Agiliti's key competitors?

Some companies that are related to Agiliti include Syneos Health (SYNH), Hill-Rom (HRC), Teva Pharmaceutical Industries (TEVA), Ascendis Pharma A/S (ASND), Neurocrine Biosciences (NBIX), CRISPR Therapeutics (CRSP), United Therapeutics (UTHR), Biohaven Pharmaceutical (BHVN), Evotec (EVTCY), Mirati Therapeutics (MRTX), Organon & Co. (OGN), Stevanato Group (STVN), Aurora Cannabis (ACBFF), Jazz Pharmaceuticals (JAZZ) and Hikma Pharmaceuticals (HKMPF).
View all of AGTI's competitors.

When did Agiliti IPO?

(AGTI) raised $500 million in an initial public offering on Friday, April 23rd 2021. The company issued 26,300,000 shares at a price of $18.00-$20.00 per share. BofA Securities, Goldman Sachs, Morgan Stanley, BMO Capital Markets, Citigroup, Jefferies and UBS Investment Bank acted as the underwriters for the IPO and KeyBanc Capital Markets, Raymond James, MUFG, SMBC Nikko, Mischler Financial Group and Siebert Williams Shank were co-managers.

What is Agiliti's stock symbol?

Agiliti trades on the New York Stock Exchange (NYSE) under the ticker symbol "AGTI."

Who are Agiliti's major shareholders?

Agiliti's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (3.76%), JPMorgan Chase & Co. (3.31%), BlackRock Inc. (2.19%), Vanguard Group Inc. (2.14%), Massachusetts Financial Services Co. MA (1.51%) and Citadel Advisors LLC (0.75%).

Which institutional investors are buying Agiliti stock?

AGTI stock was bought by a variety of institutional investors in the last quarter, including Price T Rowe Associates Inc. MD, JPMorgan Chase & Co., BlackRock Inc., Vanguard Group Inc., Massachusetts Financial Services Co. MA, Citadel Advisors LLC, Monashee Investment Management LLC, and Geode Capital Management LLC.

How do I buy shares of Agiliti?

Shares of AGTI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Agiliti's stock price today?

One share of AGTI stock can currently be purchased for approximately $19.17.

How much money does Agiliti make?

Agiliti has a market capitalization of $2.50 billion.

How many employees does Agiliti have?

Agiliti employs 3,675 workers across the globe.

What is Agiliti's official website?

The official website for Agiliti is www.agilitihealth.com.

How can I contact Agiliti?

The company can be reached via phone at (952) 893-3200 or via email at [email protected].